Capricorn Fund Managers Ltd

Position in ABBV — AbbVie Inc.

CIK 1901361 LONDON, X0

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$6,894,181

+$935,608 QoQ

Shares Held

27,397

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

#1,119

of 4,153 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capricorn Fund Managers Ltd holds $34,667,354 across 6 Drug Manufacturers - General names. ABBV ranks #2 (19.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	426,416	$22,352,726
2	ABBV	AbbVie Inc. This page	27,397	$6,894,181
3	GILD	Gilead Sciences, Inc.	31,200	$3,941,808
4	PFE	Pfizer Inc	22,130	$532,890
5	MRK	Merck & Co., Inc.	4,000	$514,000
6	JNJ	Johnson & Johnson	1,700	$431,749

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,894,181	27,397	0.0%	Shares	Sole	2026-07-24
2026-03-31	$5,958,573	27,397	-7.2%	Shares	Sole	2026-04-24
2025-09-30	$6,838,533	29,535	-5.9%	Shares	Sole	2025-10-17
2025-06-30	$5,827,354	31,394	-8.3%	Shares	Sole	2025-07-22
2025-03-31	$7,169,355	34,218	+0.6%	Shares	Sole	2025-05-08
2024-12-31	$6,043,577	34,010	-0.5%	Shares	Sole	2025-01-17
2024-09-30	$6,753,421	34,198	+34.4%	Shares	Sole	2024-10-11
2024-06-30	$4,364,669	25,447	0.0%	Shares	Sole	2024-07-12
2024-03-31	$4,633,898	25,447	0.0%	Shares	Sole	2024-04-12
2023-12-31	$3,943,521	25,447	—	Shares	Sole	2024-01-10
No filing history on record for this holder in this stock.